Ultragenyx: A Promising Bet On Rare Genetic Disorder Therapies
Seeking Alpha,
Summary Ultragenyx's pipeline boasts a diverse array of gene therapy candidates, including UX111, DTX401, DTX301, and UX701…
Synthetic and modified glycerides: effects on plasma lipids
Overview of attention for article published in Current Opinion in Lipidology, February 2001
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (89th percentile)
Readers on
- mendeley
- 19 Mendeley